Jamieson Wellness Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
The ODAC Meeting is scheduled for April 28, 2023. AstraZeneca and Merck are committed to working with the FDA to bring LYNPARZA in combination with...
Fourth Circuit Adopts Objective Reasonableness Standard In Determining Scienter Element Of The False Claims Act – Food, Drugs, Healthcare, Life Sciences
The Fourth Circuit, in United States ex rel. Sheldon v. Allergan Sales, LLC, No. 20-2330, 2022 WL 211172 (4th Cir. Jan. 25, 2022) recently upheld...